Correlation of Serum FGF23 and Chronic Kidney Disease-Mineral and Bone Abnormality Markers With Cardiac Structure Changes in Maintenance Hemodialysis Patients

Tabel 1

Baseline clinical and laboratory characteristics.

Parameters	Mean ± SD/median, n%
Dialysis (mon)	50.8 ± 33.7
Age (y)	57.5 ± 14.3
Weight (kg)	55.9 ± 11.2
FGF23 (pg/ml)	3520.4 ± 3678.2
PTH (pmol/l)	59.6 ± 48.3
Calcium (mmol/l)	2.3 ± 0.2
Phosphorus (mmol/l)	2.2 ± 0.4
Serum creatinine (umol/l)	1002.3 ± 254.2
BUN (mmol/l)	26.8 ± 3.8
UA (mmol/l)	453 ± 102.4
Glucose (mmol/l)	7.95 ± 3.41
Hemoglobin (g/l)	109 ± 13.6
ALB (g/l)	40.1 ± 3.3
TG (mmol/l)	1.9 ± 1.2
CHOL (mmol/l)	3.8 ± 1.3
LDL (mmol/l)	2.11 ± 0.68
HDL (mmol/l)	1.07 ± 0.27
BNP (pg/ml)	160.27
Gender (women %)	49 (45.8)
Death (%)	14 (13.0)
Hypertension (yes %)	80 (74.7)
Diabetes (ye s%)	30 (28.0)
Coronary heart disease (yes %)	25 (23.3)
Heart failure (yes %)	52 (48.5)
Stroke (yes %)	8 (7.4)